Primary Rodent Production Support Center

国家癌症研究所(NCI)管理着一项培育实验动物的计划，以支持NCI/NIH的许多癌症研究活动。其中包括NIH校园实验室、NCI/NIH资助的研究承包商、NCI/NIH资助的受赠者、其他政府机构以及外国的合作者。动物生产计划由生物测试科(BTB)、开发治疗计划(DTP)、癌症治疗和诊断科(DCTD)管理。生产符合基因定义和无病原体的实验动物需要严格的屏障建设和隔离操作，以提供所需的动物质量。为了最大限度地减少实验研究中的变量，这一努力的质量至关重要。生产不含病原体的最高质量的啮齿动物是这项努力的主要目标。提供动物是为了支持癌症、传染病、生物恐怖主义威胁和其他国家公认的健康问题的起因和治疗方面的研究。

The National Cancer Institute (NCI) administers a program to produce laboratory animals in support of many NCI/NIH cancer research activities. These include NIH on-campus laboratories, NCI/NIH-funded research contractors, NCI/NIH-funded grantees, other governmental agencies as well as collaborators in foreign countries. The Animal Production Program is managed by the Biological Testing Branch (BTB), Developmental Therapeutics Program (DTP), Division of Cancer Treatment and Diagnosis (DCTD). The production of genetically-defined and pathogen-free laboratory animals requires strict barrier building and isolator operations to provide the required quality of animals. The quality of this effort is of critical importance in order to minimize variables within experimental studies. The production of the highest quality rodents free from pathogenic organisms is the primary objective of this effort. Animals are provided to support research in the cause and treatment of cancer, infectious disease, bioterrorism threat and other nationally recognized health issues.